Innoviva Inc (INVA) financials
Innoviva revenue and earnings by year
Innoviva's revenue was $411 million in the fiscal year to December 31, 2025, up 14.7% from the year before. Net income was $271 million, 65.9% of revenue. Since the fiscal year to December 31, 2016, revenue has grown 13.3% a year on average.
Fiscal years, each labelled by the calendar year it ended in.
Income statement, the last 10 fiscal years
| Fiscal year to | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 411 | 359 | 310 | 331 | 392 | 337 | 261 | 261 | 217 | 134 |
| Revenue growth | 14.7% | 15.5% | -6.3% | -15.4% | 16.4% | 29.0% | 0.0% | 20.2% | 62.6% | — |
| Gross profit | 308 | 296 | 246 | 318 | — | — | — | — | — | — |
| Gross margin | 74.8% | 82.6% | 79.2% | 95.8% | — | — | — | — | — | — |
| Operating income | 164 | 167 | 114 | 470 | 371 | 321 | 246 | 238 | 184 | 109 |
| Operating margin | 39.8% | 46.5% | 36.7% | 141.9% | 94.8% | 95.2% | 94.4% | 91.3% | 84.5% | 81.6% |
| Net income | 271 | 23 | 180 | 214 | 266 | 224 | 157 | 395 | 134 | 60 |
| Net margin | 65.9% | 6.5% | 57.9% | 64.6% | 67.8% | 66.6% | 60.3% | 151.4% | 61.8% | 44.6% |
| Diluted EPS | $3.30 | $0.36 | $2.20 | $2.37 | $2.87 | $2.02 | $1.43 | $3.53 | $1.16 | $0.52 |
| Free cash flow | 196 | 185 | 141 | 202 | 364 | 313 | 257 | 224 | 142 | 61 |
Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open INVA in Markets.
How Innoviva makes money
Revenue by segment in the quarter to June 30, 2026, as the company reports it.
| Segment | Revenue | Share |
|---|---|---|
| Royalty | $56.3M | 47.1% |
| Xacduro | $22.4M | 18.7% |
| Giapreza | $22.3M | 18.6% |
| License & Other Revenue | $11.5M | 9.6% |
| Xerava | $6.74M | 5.6% |
| ZEVTERA | $351K | 0.3% |
See also: INVA valuation and P/E history · INVA returns
No forecast, no recommendation. This page describes Innoviva Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.